Jun 24, 2020 / 04:30PM GMT
Tazeen Ahmad - BofA Merrill Lynch, Research Division - VP
Okay, everybody. Good morning or rather good afternoon now. Thanks for joining us. I am Tazeen Ahmad. I am one of the senior biotech analyst here at Bank of America. It is my pleasure to have our next presenting company with us, Sarepta. We're going to be spending the next 15 minutes talking about a lot of exciting things that are happening at the company.
Joining us from Sarepta are several members of management, including Doug Ingram, Sandy Mahatme; and Ian Estepan. Gentlemen, good afternoon. Thanks for joining us.
Douglas S. Ingram - Sarepta Therapeutics, Inc. - President, CEO & Director
Thank you.
Tazeen Ahmad - BofA Merrill Lynch, Research Division - VP
So we usually like to try to start these conversations off with a quick recap from maybe Doug and others. There's been tons of things happening at the company, but maybe you could spend the first 2 minutes talking to us about what you think the most meaningful updates have been so far this year
Sarepta Therapeutics Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) Transcript
Jun 24, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers